Riskpilot← Back to searchSign inGet full accessAmyloiDia Sweden AB
ABActiveOrg 5592162332StockholmResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20190 employees
Revenue 2024
SEK 20K
-20% vs 2023
EBITDA margin
-230.0%
-667% vs 2023
Equity ratio
97.3%
Financial strength
Net profit 2024
SEK -44K
-1367% vs 2023
| Revenue | SEK 20K | -20% |
| EBITDA | SEK -46K | -667% |
| Net profit | SEK -44K | -1367% |
| Total assets | SEK 295K | -66% |
| Equity | SEK 287K | -13% |
| Employees | 0 | — |
Legal name
AmyloiDia Sweden AB
Org number
5592162332
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
27 augusti 2019
Share capital
SEK 56 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas tre i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Utbildning och implementering av innovativa metoder för diagnosticering och behandling av amyloidsjukdomar såsom Alzheimers, Parkinsons, Creutzfeld-Jakob, Typ 2 diabetes och amyotrofisk lateralskleros (ALS).
Address
Stockholm
Email
vladana.vukojevic@amyloidia.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 60 | 84 | 112 | 25 | 20 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −313 | 76 | −80 | −6 | −46 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −313 | 76 | −80 | −6 | −46 |
| Net financials | — | — | — | 2 | 3 |
| Profit before tax | −313 | 76 | −80 | −3 | −44 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −313 | 76 | −80 | −3 | −44 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 694 | 414 | 345 | 873 | 295 |
| Equity | 338 | 414 | 334 | 331 | 287 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 356 | 0 | 11 | 543 | 8 |
| Total debt | 356 | — | 11 | 543 | 8 |
EBITDA margin
-230.0%
This company
15.8%
Market median
-1556% vs market
20202024
Equity ratio
97.3%
This company
38.2%
Market median
+155% vs market
20202024
Return on equity
-15.3%
This company
18.4%
Market median
-183% vs market
20202024
Net profit margin
-220.0%
This company
8.1%
Market median
-2816% vs market
20202024
Asset turnover
0.07×
This company
1.12×
Market median
-94% vs market
20202024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-08-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
VV Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (1) | ||
RH Chief Executive Officer | Chief Executive Officer | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2022 | |
| Chairman | 2025 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AmyloiDia Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Vladana Vukojevic | Chief Executive Officer | 0 companies |
| Rudolf Hendrik Adalbert Rigler | Chief Executive Officer | 0 companies |
| Johann Georg Wilhelm Rigler | Board of Directors | 0 companies |
| Ruth Astrid Olivia Gräslund | Chairman | 0 companies |
| Ann Tiiman | Board of Directors | 0 companies |
| Jüri Jarvet | Board of Directors | 0 companies |
| Lars Yngve Terenius | Board of Directors | 0 companies |
| Sebastian Karl Thorild S Wärmländer | Board of Directors | 0 companies |